Senseye, Inc. is a neurotechnology company developing software that uses eye-tracking as a non-invasive window into brain function. The company focuses on quantifying neurological health by analyzing how the brain controls eye movements during structured visual tasks.

Its platform captures high-resolution oculomotor data using camera-based eye tracking and applies proprietary analytics to extract digital biomarkers linked to neural circuit integrity. These biomarkers are designed to reflect dysfunction across cognitive, sensory, and motor pathways, enabling objective assessment without MRI, EEG, or invasive procedures.

Senseye’s technology is positioned for clinical, research, and screening use cases, including neurodegenerative disease, brain injury, and neurological monitoring. The company positions its platform as a scalable neurodiagnostic measurement layer that can be deployed across care settings to support earlier detection, longitudinal tracking, and data-driven neurological evaluation.